The Licensed Treatment Centers deploy the Stemedica CSP™ (Condition Specific Protocols) treatment methodology which is designed to treat patient specific medical conditions on a customized basis. These protocols include: patient health and physiological assessment; pre and post patient therapy; number and kind of cells required for treatment; transplantation methodologies; and, use of adjunct therapies including pharmaceutical compounds and medical devices supportive to treatment.

The Stemedica CSP™ disciplines have been established after the treatment of approximately 3,800 patients. Treatment experience has come from both autologous (from the patient) stem cells treatment as well as from allogenic (donated) cell therapies.

The protocols offered by Stemedica Licensed Treatment Centers are non-surgical and therefore minimize patient recovery time and risk from adverse treatment response. Depending on the complexity and severity of the medical condition, patients can benefit greatly from just one stem cell treatment while others seek multiple treatments in order to maximize treatment results.

Patient Preparation:
• Stemedica uses established protocols for creating the optimal physiological environment and conditions in the patient prior to transplantation.

Multiple Cell Technology:
• Formulated preparations are developed prior to transplantation that combine cell lines that can achieve optimal therapeutic outcomes for disease specific conditions. (Stemedica MCT™ Formulations)

Number of Cells:
• Stemedica incorporates a proprietary algorithm of cell density in its CSP™ process. The number of cells used in treatment as calculated by specific patient parameters and disease specific conditions have a significant impact on treatment outcomes.

Transplantation Methodology:
• Stemedica deploys customized protocols that define the injection instrumentation, support medications and monitoring equipment used to transplant cells in predetermined single or multiple transplantation sites.

Number of Treatments:
• Stemedica has established an assessment and evaluation criteria for determining the number of treatments and the appropriate milestones between treatments.

Patient Therapy Management:
• Stemedica has developed comprehensive protocols for pre and post-treatment therapy, including: patient management and monitoring; use of adjunct therapies; pharmaceutical compounds; and, medical devices supportive to treatment.